We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

9888:HKEXBaidu, Inc. Class A Analysis

Data as of 2026-07-23 - not real-time

HK$106.80

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Baidu (9888.HK) is trading at HK$106.8, which sits below its 20‑day SMA of 108.9 and well under the 50‑day SMA of 118.1, indicating a short‑term bearish bias. The RSI of 44.3 suggests neutral momentum, while the MACD line is marginally above its signal (-2.46 vs -2.48), producing a tiny bullish histogram that does not outweigh the overall bearish trend. Volatility is elevated at 50% over the past 30 days and beta is around 0.83, implying higher price swings relative to the market. The stock holds support near HK$98.5 and faces resistance around HK$119.2, leaving a comfortable cushion above the support level. Valuation metrics are attractive: a forward PE of 12.45 beats the industry average of 15.30, price‑to‑book is under 1 (0.93), and the DCF‑derived fair value of HK$45.9 suggests a potential upside of roughly 66%. However, profitability remains thin with a profit margin of just 1% and ROE of 0.3%, reflecting ongoing earnings pressure. The company announced a voluntary conversion to a dual‑primary listing on the Hong Kong Main Board, a move that could broaden its investor base and improve liquidity.
Given the juxtaposition of a bearish technical backdrop and a materially undervalued valuation, investors should weigh short‑term price weakness against long‑term growth catalysts such as AI‑driven cloud services, autonomous driving platforms, and the strategic benefits of the dual listing. Regulatory scrutiny in China’s internet sector and the company’s modest cash conversion efficiency add layers of risk, but the strong balance sheet (cash > HK$116bn) and low debt‑to‑equity relative to peers provide a cushion. The consensus analyst view remains a strong‑buy, underscoring belief in Baidu’s strategic turnaround despite current earnings challenges.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below 20‑day and 50‑day SMAs indicating bearish bias
  • High 30‑day volatility (≈50%) and elevated beta
  • Support level at HK$98.5 provides downside cushion

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Forward PE of 12.45 vs industry 15.30 suggests valuation advantage
  • Dual‑primary listing announcement could attract new capital
  • Strong cash position and modest debt relative to equity

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Strategic AI, cloud, and autonomous‑driving growth opportunities
  • Undervaluation relative to DCF fair value and price‑to‑book
  • Potential for improved earnings as AI services scale

Key Metrics & Analysis

Financial Health

Revenue Growth-1.20%
Profit Margin1.02%
P/E Ratio12.4
ROE0.32%
ROA1.25%
Debt/Equity32.20
P/B Ratio0.9
Op. Cash FlowHK$5.7B
Free Cash FlowHK$8.0B
Industry P/E15.3

Technical Analysis

TrendBearish
RSI44.3
SupportHK$98.50
ResistanceHK$119.20
MA 20HK$108.88
MA 50HK$118.08
MA 200HK$124.07
MACDBullish
VolumeStable
Fear & Greed Index88.04

Valuation

Fair ValueHK$45.88
Target PriceHK$178.06
Upside/Downside66.72%
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.83
Volatility50.14%
Sector RiskHigh
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.